CareLit Fachartikel

The impact of prior therapies on overall survival in mCRPC patients receiving Lu-PSMA-617 therapy. A WARMTH retrospective multicenter trial

H Ahmadzadehfar, K Rahbar, RP Baum, C Gerke, C Kratochwil, H Ilhan, M Sathekge, L Kabasakal, F. O Garcia-Perez, K Kairemo, M Maharaj, D Paez, I Virgolini · Nuklearmedizin - NuclearMedicine · 2020 · Heft 02

Dokument
1214665
CareLit-ID
Jahr
2020
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Nuklearmedizin - NuclearMedicine
Autor:innen
H Ahmadzadehfar, K Rahbar, RP Baum, C Gerke, C Kratochwil, H Ilhan, M Sathekge, L Kabasakal, F. O Garcia-Perez, K Kairemo, M Maharaj, D Paez, I Virgolini
Ausgabe
Heft 02 / 2020
Jahrgang 59
Seiten
–
Erschienen: 2020-04-01 00:00:00
ISSN
0029-5566
DOI
10.1055/s-0040-1708133

Zusammenfassung

The impact of prior therapies on overall survival in mCRPC patients receiving Lu-PSMA-617 therapy. A WARMTH retrospective multicenter trial

Schlagworte

Impact Prior Therapies Overall Survival Mcrpc Patients Receiving Lu-Psma-617 Therapy Warmth Retrospective Nuklearmedizin - NuclearMedicine